Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Depreciation & Amortization (CF) (2016 - 2025)

Historic Depreciation & Amortization (CF) for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $864000.0.

  • STRATA Skin Sciences' Depreciation & Amortization (CF) fell 3026.63% to $864000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.5 million, marking a year-over-year decrease of 966.71%. This contributed to the annual value of $5.0 million for FY2024, which is 1053.48% down from last year.
  • STRATA Skin Sciences' Depreciation & Amortization (CF) amounted to $864000.0 in Q3 2025, which was down 3026.63% from $1.2 million recorded in Q2 2025.
  • STRATA Skin Sciences' Depreciation & Amortization (CF)'s 5-year high stood at $2.2 million during Q4 2021, with a 5-year trough of $481000.0 in Q1 2021.
  • In the last 5 years, STRATA Skin Sciences' Depreciation & Amortization (CF) had a median value of $1.2 million in 2024 and averaged $1.2 million.
  • As far as peak fluctuations go, STRATA Skin Sciences' Depreciation & Amortization (CF) crashed by 5366.09% in 2021, and later surged by 17463.62% in 2022.
  • Over the past 5 years, STRATA Skin Sciences' Depreciation & Amortization (CF) (Quarter) stood at $2.2 million in 2021, then crashed by 38.8% to $1.3 million in 2022, then fell by 3.25% to $1.3 million in 2023, then decreased by 3.83% to $1.2 million in 2024, then fell by 29.76% to $864000.0 in 2025.
  • Its last three reported values are $864000.0 in Q3 2025, $1.2 million for Q2 2025, and $1.2 million during Q1 2025.